The Board of Directors of Autobio Diagnostics Co., Ltd. has authorized a buyback plan on January 29, 2024.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54.4 CNY | -2.60% | -4.59% | -4.58% |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
Apr. 19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.58% | 4.49B | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+24.20% | 5.27B | |
-51.47% | 3.11B | |
+16.25% | 2.87B | |
+31.06% | 2.31B | |
-4.08% | 1.89B | |
+3.02% | 1.64B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.